{"preliminary_commentary":{"by_channel":{"x_thread":3},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build."},"free_build":{"available":false},"name":"NCT07832292","nct_id":"NCT07832292","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=nct07832292. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"Participants will receive JNJ-101556143 orally once daily in a 28-day treatment cycle until confirmed radiographic progression by blinded independent central review (BICR) or unequivocal clinical progression, or any other protocol-defined discontinuation criteria is met.","label":"JNJ-101556143","type":"EXPERIMENTAL"}],"collaborators":[],"completion_date":{"date":"2030-05-20","type":"ESTIMATED"},"conditions":["Prostatic Neoplasms"],"enrollment":{"count":100,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"JNJ-101556143","otherNames":[],"type":"DRUG"}],"last_update":"2026-09-25","lead_sponsor":"Janssen Research & Development, LLC","official_title":"A Phase 2, Open-label, Multicenter, Single-arm Trial of JNJ-101556143, an Androgen Receptor-targeted Regulated Induced Proximity Targeting Chimera (RIPTAC™) Therapeutic in Participants With Metastatic Androgen Pathway Modulation-Resistant Prostate Cancer","overall_status":"RECRUITING","phases":["PHASE2"],"primary_completion_date":{"date":"2029-05-17","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Overall Response Rate (ORR)","timeFrame":"Up to 2 years and 8 months"}],"references":[],"start_date":{"date":"2026-09-16","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer","url":"https://clinicaltrials.gov/study/NCT07832292"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/nct07832292"}